Log In
Print
BCIQ
Print
Print this Print this
 

Lamazym

  Manage Alerts
Collapse Summary General Information
Company Zymenex A/S
DescriptionRecombinant human mannosidase enzyme Lamazym (rhLaman)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase III
Standard IndicationGlycosphingolipid storage disorders
Indication DetailsTreat alpha-mannosidosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today